ClinicalTrials.Veeva

Menu
T

The Retina Group of Washington | Chevy Chase, MD

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

APL-2
bevacizumab
JNJ-81201887
Zimura
ranibizumab
Pegcetacoplan
zeaxanthin
Avacincaptad pegol
DHA
EPA

Parent organization

This site is a part of The Retina Group of Washington

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 12 total trials

A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)

The purpose of this study is to assess the long-term safety and tolerability after an intravitreal injection (a shot of medicine into the eye) of JNJ...

Enrolling
Macular Degeneration
Geographic Atrophy
Other: Sham Procedure
Drug: JNJ-81201887

This study is researching experimental (study) drugs called pozelimab and cemdisiran. The study is focused on participants who have Geographic Atroph...

Enrolling
Age-related Macular Degeneration (AMD)
Geographic Atrophy (GA)
Drug: Placebo
Drug: Pozelimab

Trial sponsors

A
Janssen (J&J Innovative Medicine) logo
Astellas logo
C
I
National Institutes of Health (NIH) logo
N
Regeneron Pharmaceuticals logo
The EMMES Corporation logo
University of Pennsylvania logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems